265 related articles for article (PubMed ID: 17277119)
1. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling.
Sacre SM; Lundberg AM; Andreakos E; Taylor C; Feldmann M; Foxwell BM
J Immunol; 2007 Feb; 178(4):2148-54. PubMed ID: 17277119
[TBL] [Abstract][Full Text] [Related]
2. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
3. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
[TBL] [Abstract][Full Text] [Related]
4. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
5. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo.
Piao W; Vogel SN; Toshchakov VY
J Immunol; 2013 Mar; 190(5):2263-72. PubMed ID: 23345333
[TBL] [Abstract][Full Text] [Related]
7. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
8. Engagement of Fas differentially regulates the production of LPS-induced proinflammatory cytokines and type I interferons.
Brennan K; Lyons C; Fernandes P; Doyle S; Houston A; Brint E
FEBS J; 2019 Feb; 286(3):523-535. PubMed ID: 30536547
[TBL] [Abstract][Full Text] [Related]
9. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
10. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
[TBL] [Abstract][Full Text] [Related]
11. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
[TBL] [Abstract][Full Text] [Related]
12. Lipoteichoic Acid Inhibits Lipopolysaccharide-Induced TLR4 Signaling by Forming an Inactive TLR4/MD-2 Complex Dimer.
Watanabe S; Zenke K; Muroi M
J Immunol; 2023 May; 210(9):1386-1395. PubMed ID: 36897262
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
15. Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.
Rallabhandi P; Nhu QM; Toshchakov VY; Piao W; Medvedev AE; Hollenberg MD; Fasano A; Vogel SN
J Biol Chem; 2008 Sep; 283(36):24314-25. PubMed ID: 18622013
[TBL] [Abstract][Full Text] [Related]
16. Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells.
Keck S; Müller I; Fejer G; Savic I; Tchaptchet S; Nielsen PJ; Galanos C; Huber M; Freudenberg MA
J Immunol; 2011 May; 186(9):5478-88. PubMed ID: 21441453
[TBL] [Abstract][Full Text] [Related]
17. TRIF signaling is essential for TLR4-driven IgE class switching.
Janssen E; Ozcan E; Liadaki K; Jabara HH; Manis J; Ullas S; Akira S; Fitzgerald KA; Golenbock DT; Geha RS
J Immunol; 2014 Mar; 192(6):2651-8. PubMed ID: 24532577
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
19. Differential role for p120-catenin in regulation of TLR4 signaling in macrophages.
Yang Z; Sun D; Yan Z; Reynolds AB; Christman JW; Minshall RD; Malik AB; Zhang Y; Hu G
J Immunol; 2014 Aug; 193(4):1931-41. PubMed ID: 25015829
[TBL] [Abstract][Full Text] [Related]
20. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
